LEXX financials

Lexaria Bioscience (LEXX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

LEXX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$705.92K$703.20K-$11.88M-$11.90M-0.66
2024$464.28K$459.46K-$5.75M-$5.80M-0.47
2023$226.21K$194.71K-$6.53M-$6.66M-1.01
2022$255.40K$183.56K-$6.62M-$7.27M–
2021$722.74K$547.39K-$5.69M-$4.03M-0.95
2020$314.79K$215.41K–-$3.93M-1.47